KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection?

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3862-3865

Blackwell Publishing

Access to resources Recommend Favorite

Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

By Lentz Frederike   Tran Agnès   Rey Elisabeth   Pons Gérard   Tréluyer Jean-Marc  

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

Hepatic arterial chemotherapy for colorectal cancer metastases?

By  

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

No Duplicate KRAS Mutation is Identified on the Same Allele in Gastric or Colorectal Cancer Cells with Multiple KRAS Mutations

By Kimura K   Nagasaka T   Hoshizima N   Sasamoto H   Notohara K   Takeda M   Kominami K   Iishii T   Tanaka N   Matsubara N  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 450-457

Field House Publishing

Access to resources Recommend Favorite

KRAS Mutation Testing of Colorectal Cancer for Anti-EGFR Therapy: Dogmas Versus Evidence

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 813-823

Bentham Science Publishers

Access to resources Recommend Favorite